Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1

Immunology Letters

Volumn 84, Issue 2, 2002, Pages 153-157

  Li, Hua ^a   Liu, Zu Qiang ^a   Ding, Jian ^a   Chen, Ying Hua ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

HIV 1; Neutralizing epitope; Recombinant multi epitope vaccine

Indexed keywords

AMINO ACID; ANTIGEN; ENVELOPE PROTEIN; EPITOPE; GLUTAMYLLEUCYLASPARTYLLYSYLTRYPTOPHYLALANINE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYBRID PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS ANTIBODY; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS FUSION PROTEIN;

AFRICA; ANIMAL CELL; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; ASIA; CELL SURFACE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; WESTERN HEMISPHERE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; BASE SEQUENCE; ESCHERICHIA COLI; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; IMMUNODOMINANT EPITOPES; MICE; MOLECULAR SEQUENCE DATA; VACCINES, DNA; VIRAL FUSION PROTEINS;

EID: 0036830265     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(02)00175-X     Document Type: Article

References (21)

1. Shibata R., Igarashi T., Haigwood N., Buckler-White A., Ogert R., Ross W., Willey R., Cho M.W., Martin M.A. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:1999;204-210.
2. Igarashi T., Brown C., Azadegan A., Haigwood N., Dimitrov D., Martin M.A., Shibata R. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat. Med. 5:1999;211-216.
3. Mascola J.R., Louder M.K., Vancott T.C., Sapan C.V., Lambert J.S., Muenz L.R., Bunow B., Birx D.L., Robb M.L. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J. Virol. 71:1997;7198-7206.
4. Zwick M.B., Wang M., Poignard P., Stiegler G., Katinger H., Burton D.R., Parren P.W. Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J. Virol. 75:2001;12 198-12 208.
5. + by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins. J. Virol. 72:1998;3235-3240.
6. Geffin R.B., Scott G.B., Melenwick M., Hutto C., Lai S., Boots L.J., McKenna P.M., Kessler J.A. II, Conley A.J. Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1. AIDS Res. Hum. Retroviruses. 14:1998;579-590.
7. Chen Y.H., Xiao Y., Yu T., Dierich M.P. Epitope-vaccine: a new strategy against HIV-1. Immunol. Today. 20:1999;588-589.
8. Xiao Y., Lu Y., Chen Y.H. Epitope-vaccine as a new strategy against HIV-1 mutation. Immunol. Lett. 77:2001;3-6.
9. Muster T., Steindl F., Purtscher M. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type I. J. Virol. 67:1993;6642-6647.
10. Purtscher M., Trkola A., Gruber G. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 10:1994;1651-1658.
11. Catasi P., Bradbury E.M., Gupta G. Structure and polymorphism of HIV-1 third variable loops. J. Biol. Chem. 271:1995;8236-8242.
12. Emini E.A., Schleif W.A., Numberg J.H., Conley A.J., Eda Y., Tokiyoshi S., Putney S.D., Matsushita S., Cobb K.E., Jett C.M., Eichbereg J.W., Murthy K.K. Prevention of HIV-1 infection in chimpanzees by gp120 V3 dominant-specific monoclonal antibody. Nature. 355:1992;728-730.
13. Chen Y.H., Yu T., Bai Y., Dierich M.P. Immunogenicity of the GPGRAFY-epitope on synthetic peptides. Immunol. Lett. 69:1999;353-354.
14. Xiao Y., Zhao Y., Lu Y., Chen Y.H. Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody. Immunol. Invest. 291:2001;45-50.
15. Ding J., Lu Y., Chen Y.H. Candidate multi-epitope vaccines in aluminum adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1. FEMS Immunol. Med. Mic. 29:2000;123-127.
16. Tian H.J., Xiao Y., Zhu M., Dierich M.P., Chen Y.H. Induction of monoclonal antibodies with predefined epitope-specificity by epitope-vaccines. Immunol. Lett. 75:2001;161-162.
17. Shi Q.L., Kim S.Y., Blass J.P., Cooper A.J.L. Expression in Escherichia coli and purification of hexahistidine-tagged human tissue transglutaminase. Protein Express. Purif. 24:2002;366-373.
18. Xia Z.X., Ao S.Z. Expression and function analysis of yeast PHO81 ankyrin repeats. Acta Biochim. Biophys. Sin. 31:1999;185-190.
19. Weiss C.D., White J.M. Charachterization of stable hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidyliositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 67:1993;7060-7066.
20. Dong X.N., Xiao Y., Chen Y.H. ELNKWA-epitope specific antibodies induced by epitope vaccine recognize ELDKWA and other two neutralizing-resistant mutated epitopes on HIV-1 gp41. Immunol. Lett. 75:2001;149-152.
21. Ding J., He F., Lu Y., Xiao Y., Chen Y.H. Induction of multi-epitope specific antibodies against HIV-1 by multi-epitope vaccine. Chinese Sci. Bull. 46:2001;1859-1864.